ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2283

Suppression of Monosodium Urate (MSU) Crystals-Induced Inflammatory Response By Inhibiting TGF-β Activated Kinase 1 (TAK1)

Anil Singh1, Kayla O’Sullivan2, Mukesh Chourasia3, Sadiq Umar4, Mahamudul Haque2, Bhanupriya Madarampalli2 and Salahuddin Ahmed2, 1Washington State University, College of Pharmacy, Spokane, WA, 2Department of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA, 3Department of Pharmacoinformatics,, National lnstitute of Pharmaceutical Education and Research, Hajipur,, India, 4Department of Pharmaceutical Science, Washington State University, College of Pharmacy, Spokane, WA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: gout, interleukins (IL), signal transduction and therapeutic targeting, Sodium Urate Crystals

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Monosodium urate (MSU) crystals are known to activate inflammatory pathways that overlap with interleukin-1β (IL-1β) signaling. The present study was carried out to determine if MSU utilizes IL-1β signaling proteins to elicit inflammatory responses.

Methods:   THP-1 monocytes were converted to macrophages with phorbol myristate acetate (PMA) for 3 hours followed by stimulation with MSU crystals (25-200 µg/ml) for 0-24 hours. Whole cell extracts were prepared for the detection of cellular proteins by Western blotting method, while the conditioned media was collected for the quantitation of secreted IL-1β and TNF-α by ELISA. Molecular dynamics (MD) simulation was performed using protein preparation wizard of Schrodinger suit 2014.3 on TAK1-TAB1 protein with a tautomeric form of MSU as a ligand. Recombinant human TAK1 protein was used for in vitro kinase assay. For in vivo evaluation, C57BL/6J mice were administered (5Z)-7-Oxozeaenol (an inhibitor of TAK1; 5 mg/kg, p.o.) or febuxostat (5 mg/kg. p.o.) 2 hours prior to MSU injection (0.5 mg/20 µl) in the footpad. Changes in the paw circumferences were measured up to 48 hours of MSU injection.

Results:   Stimulation of THP-1 macrophages with MSU (25-200 µg/ml) resulted in a dose- and time-dependent increase in IL-1β and TNF-α production (p<0.05). At the cellular level, MSU selectively inhibited the global expression pattern of K63-linked ubiquitination without affecting K48-linked ubiquitination in activated THP-1 cells. Interestingly, a rapid phosphorylation of IRAK-4 (Thr345/Ser346), IRAK-1 (Thr387), IRAK-1 (Thr209), and TAK1 (Thr184/187) in THP-1 macrophages was observed within 5 to 15 minutes of MSU stimulation. Blockade of IL-1β secretion by Brefeldin A in THP1 macrophages had no effect on MSU-induced TAK1 activation, suggesting TAK1 as a direct target of MSU. To evaluate the importance of IL-1β signaling proteins using chemical inhibitors, we found that the inhibition of TAK1, but not IRAK-1/4 or TRAF6, completely abrogated MSU-induced IL-1β and TNF-α production in THP-1 macrophages (p<0.01). Furthermore, in silico simulation of TAK1 revealed that MSU is capable of activating TAK1 and arresting its conformational position in active state, thereby, causing sustained TAK1 kinase activation. Furthermore, in vitro kinase assay results also showed that MSU (100-500 µg/ml) induces autophosphorylation of TAK1 protein in a dose-dependent manner (p<0.05). Findings from in vivo studies suggest that the pretreatment of mice with (5Z)-7-Oxozeaenol significantly inhibited MSU-induced paw circumferences in mice (p<0.01), which was comparable to febuxostat treatment.

Conclusion:   Our study shows that MSU is capable of inducing TAK1 activation in THP-1 macrophages independent of endogenous IL-1β, suggesting TAK1 as a potential therapeutic target for the treatment of gout.


Disclosure: A. Singh, None; K. O’Sullivan, None; M. Chourasia, None; S. Umar, None; M. Haque, None; B. Madarampalli, None; S. Ahmed, None.

To cite this abstract in AMA style:

Singh A, O’Sullivan K, Chourasia M, Umar S, Haque M, Madarampalli B, Ahmed S. Suppression of Monosodium Urate (MSU) Crystals-Induced Inflammatory Response By Inhibiting TGF-β Activated Kinase 1 (TAK1) [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/suppression-of-monosodium-urate-msu-crystals-induced-inflammatory-response-by-inhibiting-tgf-%ce%b2-activated-kinase-1-tak1/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/suppression-of-monosodium-urate-msu-crystals-induced-inflammatory-response-by-inhibiting-tgf-%ce%b2-activated-kinase-1-tak1/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology